Note 4 - R&D tax incentive receivable

R&D tax incentive is recorded within the Consolidated Statements of Operations and Comprehensive Loss and amounted to $1.8 million and $11.4 million for the fiscal years ended June 30, 2025 and 2024, respectively. In the fiscal year ended June 30, 2024, due to multiple years of tax incentives being granted and successful lodgement of overseas findings on the Company’s lead assets, the Company changed its estimates for the R&D tax incentive receivable, primarily based on historical experience of claims, which resulted in an increase in R&D tax incentive receivable in the fiscal year ended June 30, 2024.